Natixis
- SEC CIK
- 0001274981
- Latest filing
- Aug 13, 2026
BCYC holding history
Bicycle Therapeutics PLC in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BCYC overviewAll 13F holders of BCYCFull Q2 2026 holdings
- Shares (Q2 2026)
- 4,645
- Value
- $20.0K
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 4,645 | $20.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 4,645 | $21.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 4,645 | $31.6K | <0.1% | +2,698+138.6% | Added | Holders |
| Q3 2025 | 1,947 | $14.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1,947 | $13.9K | <0.1% | −179−8.4% | Reduced | Holders |
| Q1 2025 | 2,126 | $17.9K | <0.1% | −172−7.5% | Reduced | Holders |
| Q4 2024 | 2,298 | $33.2K | <0.1% | −437−16.0% | Reduced | Holders |
| Q3 2024 | 2,735 | $62.8K | <0.1% | −147−5.1% | Reduced | Holders |
| Q2 2024 | 2,882 | $57.9K | <0.1% | +314+12.2% | Added | Holders |
| Q1 2024 | 2,568 | $63.2K | <0.1% | −61−2.3% | Reduced | Holders |
| Q4 2023 | 2,629 | $47.6K | <0.1% | −139−5.0% | Reduced | Holders |
| Q3 2023 | 2,768 | $55.1K | <0.1% | −7−0.3% | Reduced | Holders |
| Q2 2023 | 2,775 | $69.9K | <0.1% | −625−18.4% | Reduced | Holders |
| Q1 2023 | 3,400 | $73.7K | <0.1% | −213−5.9% | Reduced | Holders |
| Q4 2022 | 3,613 | $106.9K | <0.1% | +3,613 | New | Holders |